John Roy M, Kumar Saurabh
From Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Circulation. 2016 May 10;133(19):1892-900. doi: 10.1161/CIRCULATIONAHA.116.018011.
Although sinus node dysfunction (SND) and atrial arrhythmias frequently coexist and interact, the putative mechanism linking the 2 remain unclear. Although SND is accompanied by atrial myocardial structural changes in the right atrium, atrial fibrillation (AF) is a disease of variable interactions between left atrial triggers and substrate most commonly of left atrial origin. Significant advances have been made in our understanding of the genetic and pathophysiologic mechanism underlying the development and progression of SND and AF. Although some patients manifest SND as a result of electric remodeling induced by periods of AF, others develop progressive atrial structural remodeling that gives rise to both conditions together. The treatment strategy will thus vary according to the predominant disease phenotype. Although catheter ablation will benefit patients with predominantly AF and secondary SND, cardiac pacing may be the mainstay of therapy for patients with predominant fibrotic atrial cardiomyopathy. This contemporary review summarizes current knowledge on sinus node pathophysiology with the broader goal of yielding insights into the complex relationship between sinus node disease and atrial arrhythmias.
尽管窦房结功能障碍(SND)与房性心律失常常并存且相互影响,但两者之间的潜在联系机制仍不清楚。虽然SND伴有右心房心肌结构改变,但心房颤动(AF)是一种左心房触发因素与通常起源于左心房的基质之间存在多种相互作用的疾病。我们对SND和AF发生发展的遗传和病理生理机制的理解取得了重大进展。虽然一些患者因房颤发作引起的电重构而出现SND,但另一些患者则发生进行性心房结构重构,从而导致两种情况同时出现。因此,治疗策略将根据主要疾病表型而有所不同。虽然导管消融对以AF为主且伴有继发性SND的患者有益,但心脏起搏可能是主要表现为纤维化心房心肌病患者的主要治疗方法。这篇当代综述总结了目前关于窦房结病理生理学的知识,其更广泛的目标是深入了解窦房结疾病与房性心律失常之间的复杂关系。